LPS-induced inflammation can activate TLR4 signaling, triggering downstream pathways like NF-κB, which exacerbate liver inflammation and fibrosis, ultimately increasing the risk of HCC [157]. The gene discussed is TLR4; the disease is hepatocellular carcinoma.